Form 4 for OMDA Omada Health, Inc.
Accepted 2026-09-03 18:20:28 ET · period of report 2026-09-01 · accession 0001610717-26-000397 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-03 18:20 | 2026-09-01 | OMDA | Duffy Sean P. | CEO, Dir | M - OptEx | $6.98 | +21.6K | 433.4K | +5% | +$150.7K |
| DMT | 2026-09-03 18:20 | 2026-09-01 | OMDA | Duffy Sean P. | CEO, Dir | S - Sale+OE | $23.62 | -21.6K | 411.9K | -5% | -$509.5K |
| DT | 2026-09-03 18:20 | 2026-09-01 | OMDA | Duffy Sean P. | CEO, Dir | F - Tax | $22.84 | -9,885 | 402.0K | -2% | -$225.8K |
| DMT | 2026-09-03 18:20 | 2026-09-01 | OMDA | Duffy Sean P. | CEO, Dir | M - OptEx | $0.00 | -21.6K | 513.0K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | M | A | 12,944 | $5.82 | 424,805 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. |
| 2 | Common | Common Stock | 2026-09-01 | M | A | 4,314 | $8.28 | 429,119 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. |
| 3 | Common | Common Stock | 2026-09-01 | M | A | 4,314 | $9.18 | 433,433 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. |
| 4 | Common | Common Stock | 2026-09-01 | S | D | 7,344 | $23.12 | 426,089 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F2) This transaction was executed in multiple trades at prices ranging from $22.69 to $23.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-09-01 | S | D | 5,600 | $24.27 | 420,489 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F3) This transaction was executed in multiple trades at prices ranging from $23.75 to $24.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2026-09-01 | S | D | 4,933 | $23.13 | 415,556 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F4) This transaction was executed in multiple trades at prices ranging from $22.71 to $23.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2026-09-01 | S | D | 3,695 | $24.27 | 411,861 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F5) This transaction was executed in multiple trades at prices ranging from $23.76 to $24.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2026-09-01 | F | D | 9,885 | $22.84 | 401,976 | D | — | — | |
| 9 | Derivative | Stock Option (Right to Buy) | 2026-09-01 | M | D | 12,944 | $0.00 | 129,539 | D | $5.82 · — to 2029-08-21 | 12,944 Common Stock | (F7) 100% of the shares subject to the option are fully vested and exercisable. |
| 10 | Derivative | Stock Option (Right to Buy) | 2026-09-01 | M | D | 4,314 | $0.00 | 106,218 | D | $8.28 · — to 2031-05-05 | 4,314 Common Stock | (F7) 100% of the shares subject to the option are fully vested and exercisable. |
| 11 | Derivative | Stock Option (Right to Buy) | 2026-09-01 | M | D | 4,314 | $0.00 | 512,994 | D | $9.18 · — to 2032-02-10 | 4,314 Common Stock | (F7) 100% of the shares subject to the option are fully vested and exercisable. |